Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
14.69
+0.28 (1.94%)
Apr 27, 2026, 10:53 AM EDT - Market open
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.06 billion as of April 27, 2026. Its market cap has increased by 294.45% in one year.
Market Cap
2.06B
Enterprise Value
1.83B
1-Year Change
294.45%
Ranking
Category
Stock Price
$14.69
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.06B, an increase of 2,323.07%. That is a compound annual growth rate of 57.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 2.02B | 25.83% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 2.18B |
| Sarepta Therapeutics | 2.13B |
| Aurinia Pharmaceuticals | 2.12B |
| Zymeworks | 2.07B |
| Ocular Therapeutix | 2.07B |
| Capricor Therapeutics | 2.04B |
| Mesoblast | 2.03B |
| Stoke Therapeutics | 2.01B |